© 2023 MJH Life Sciences™ and Infection Control Today. All rights reserved.
LITTLE FALLS, N.J.Cantel Medical Corp. has expanded its Medivators Endoscope Reprocessing product line by purchasing the assets of Verimetrix, LLC. Verimetrix, based in St. Louis, designs, markets, and sells the Veriscan Pro V2.2 System, a state-of-the-art endoscope leak and fluid detection device that provides customers with superior accuracy, complete automation, and comprehensive electronic record keeping and reporting. The Veriscan System enables customers not only to reduce scope repair costs and improve the productivity of their scope inventory, but also establish greater staff efficiencies and retain accurate performance records. The business being acquired has pre-acquisition annual revenues of approximately $2 million and is expected to be accretive in 2008.
According to R. Scott Jones, Cantel Medicals president and CEO, The acquisition of the Veriscan technology advances Cantels strategy of investing in innovative new products, expansion in existing markets, and providing valuable solutions to our end users.
Roy Malkin, president and CEO of the Minntech Corporations Medivators business group, added, Since the launch of our direct hospital field sales force in August 2006, weve been adding technologically advanced products that leverage our in-depth knowledge of the endoscopy market. The Veriscan Pro V2.2 is the ideal complement to our national direct sales strategy, equipping our sales team with a sequential customer solution ranging from pre-cleaning flushing aids and leak testing, through to automated disinfection equipment and chemistries.
Source: Cantel Medical Corp.